Cannabinoid receptor type 2 gene is associated with human osteoporosis.
暂无分享,去创建一个
Jan Freudenberg | Andreas Zimmer | Uwe Kornak | Christian Kubisch | Itai Bab | U. Kornak | A. Zimmer | C. Kubisch | I. Bab | M. Karsak | J. Freudenberg | M. de Vernejoul | M. Cohen-Solal | C. Morieux | Marie-Christine de Vernejoul | Martine Cohen-Solal | Agnes Ostertag | Meliha Karsak | Caroline Morieux | Julia Essig | Edda Erxlebe | A. Ostertag | Edda Erxlebe | M. Cohen‐Solal | Julia Essig
[1] S. Munro,et al. Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.
[2] Miikka Vikkula,et al. LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.
[3] M. Devoto,et al. Variance component linkage analysis indicates a QTL for femoral neck bone mineral density on chromosome 1p36. , 2001, Human molecular genetics.
[4] S. Ralston,et al. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors , 2005, Nature Medicine.
[5] G A Churchill,et al. Quantitative Trait Loci for Femoral and Lumbar Vertebral Bone Mineral Density in C57BL/6J and C3H/HeJ Inbred Strains of Mice , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[7] M. Devoto,et al. Univariate and bivariate variance component linkage analysis of a whole-genome scan for loci contributing to bone mineral density , 2005, European Journal of Human Genetics.
[8] J. Gulcher,et al. Linkage of Osteoporosis to Chromosome 20p12 and Association to BMP2 , 2003, PLoS biology.
[9] M. Cohen-Solal,et al. [Genetics of osteoporosis]. , 2004, La Revue de medecine interne.
[10] Ivar Heuch,et al. Low bone mineral density is related to echogenic carotid artery plaques: a population-based study. , 2004, American journal of epidemiology.
[11] S. Grant,et al. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α 1 gene , 1996, Nature Genetics.
[12] Richard A. King,et al. The genetic basis of common diseases. , 2002 .
[13] M. Herkenham,et al. Cannabinoid receptor localization in brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[14] Tatiana Foroud,et al. Genetics of osteoporosis. , 2002, Endocrine reviews.
[15] E. Orwoll,et al. Phenotypic Characterization of Mice Bred for High and Low Peak Bone Mass , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] Kui Zhang,et al. Hapblock: Haplotype Block Partitioning and Tag Snp Selection Software Using a Set of Dynamic Programming Algorithms , 2022 .
[17] M. Herkenham,et al. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. Green,et al. The Genetic Basis of Common Diseases, 2nd Edition , 2004, Human Genetics.
[19] F. Mach,et al. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice , 2005, Nature.
[20] Geoffrey B. Nilsen,et al. Whole-Genome Patterns of Common DNA Variation in Three Human Populations , 2005, Science.
[21] J. Eisman,et al. Prediction of bone density from vitamin D receptor alleles , 1994, Nature.
[22] J. Ott,et al. First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q , 1998, European Journal of Human Genetics.